Market Overview

Earnings Scheduled For February 13

Share:

Alexander & Baldwin Inc (NYSE: ALEX) is estimated to post its Q4 EPS at $0.25 on revenue of $424.90 million.

Diebold Incorporated (NYSE: DBD) is projected to report its Q4 earnings at $0.84 per share on revenue of $837.7 million.

Health Management Associates Inc (NYSE: HMA) is expected to post its Q4 EPS at $0.20 on revenue of $1.58 billion.

Charles River Laboratories International Inc (NYSE: CRL) is projected to post its Q4 EPS at $0.56 on revenue of $282.74 million.

Fidelity National Information Services Inc (NYSE: FIS) is estimated to post its Q4 EPS at $0.65 on revenue of $1.49 billion.

Ecolab Inc (NYSE: ECL) is expected to post its Q4 EPS at $0.70 on revenue of $1.96 billion.

Delphi Financial Group Inc (NYSE: DFG) is estimated to post its Q4 EPS at $0.88 on revenue of $482.23 million.

Charles River Laboratories International Inc (NYSE: CRL) is projected to post its Q4 earnings at $0.55 per share on sales of $282.8 million.

Masco Corporation (NYSE: MAS) is projected to post a Q4 loss at $0.05 per share on revenue of $1.78 billion.

SEACOR Holdings Inc (NYSE: CKH) is estimated to post its Q4 EPS at $1.28 on revenue of $548.50 million.

Advanced Photonix Inc (AMEX: API) is expected to post a FQ3 loss at $0.03 per share on revenue of $6.91 million.

Lender Processing Services Inc (NYSE: LPS) is projected to post its Q4 EPS at $0.58 on revenue of $516.90 million.

ECB Bancorp Inc (AMEX: ECBE) is estimated to post a Q4 loss at $0.11 per share on revenue of $9.75 million.

Envestnet Inc (NYSE: ENV) is expected to post its Q4 EPS at $0.09 on revenue of $29.86 million.

AtriCure Inc (NASDAQ: ATRC) is projected to post a Q4 loss at $0.07 per share on revenue of $17.28 million.

Regal Entertainment Group (NYSE: RGC) is expected to post its Q4 EPS at $0.02 on revenue of $627.26 million.

Exact Sciences Corporation (NASDAQ: EXAS) is estimated to post a Q4 loss at $0.17 per share on revenue of $1.02 million.

Ellington Financial LLC (NYSE: EFC) is expected to post its Q4 EPS at $0.71 on revenue of $14.30 million.

Amicus Therapeutics Inc (NASDAQ: FOLD) is estimated to post a Q4 loss at $0.37 per share on revenue of $6.06 million.

Posted-In: Earnings ScheduledEarnings News Pre-Market Outlook Markets

 

Related Articles (API + ALEX)

View Comments and Join the Discussion!

Stocks To Watch For February 13

Here's What You Need to Know About the Facebook IPO